Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 664.49M P/E - EPS this Y 20.00% Ern Qtrly Grth -
Income -43.16M Forward P/E -13.05 EPS next Y -33.30% 50D Avg Chg -4.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 4.54 EPS next 5Y - 52W High Chg -46.00%
Recommedations 2.00 Quick Ratio 11.79 Shares Outstanding 82.11M 52W Low Chg 10.00%
Insider Own 3.14% ROA -20.70% Shares Float 79.52M Beta 0.57
Inst Own 32.12% ROE -31.88% Shares Shorted/Prior 22.12M/20.02M Price 8.22
Gross Margin - Profit Margin - Avg. Volume 877,169 Target Price 34.67
Oper. Margin - Earnings Date May 7 Volume 616,765 Change 0.86%
About Anavex Life Sciences Corp.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Anavex Life Sciences Corp. News
04/11/24 Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
03/25/24 Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
03/18/24 Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
02/26/24 12 $10 Stocks That Will Triple
02/26/24 Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
02/08/24 Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
02/07/24 Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
02/01/24 Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
01/31/24 Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal
01/31/24 GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
01/31/24 Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 530.68%: Here's is How to Trade
01/24/24 Anavex Life Sciences (AVXL) Upgraded to Strong Buy: Here's Why
01/24/24 Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans
01/16/24 Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
01/09/24 Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
01/08/24 5 Small-Cap Stocks to Play the January Effect
01/08/24 Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental Disorders
01/03/24 Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
01/03/24 Anavex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
01/02/24 Anavex Life Sciences Provides an Update on Rett Syndrome Program
AVXL Chatroom

User Image Burg2532 Posted - 1 hour ago

$AVXL deleting evidence?

User Image Trainguy1 Posted - 1 hour ago

$AVXL It looks like Anavex has started deleting links to previous investor conferences at: https://www.anavex.com/investor-material No doubt they are tidying up before dropping the link to tomorrow's Noble Capital investor's conference. I wonder if anything else is going on 🤔

User Image ForcedToRetire Posted - 1 hour ago

$AVXL An indicator is 32 total posts today. Interest is waning. I've seen days where I wouldn't attempt to count. Disclosure, I've been in and out of AVXL for 3 years. Not long now but for some reason i still buy long term calls. Lost everytime i went long. I bought the Kool aid after the Australian news stories which by the way have had zero updates. My father died of early alzheimer's so I held out hope for a real treatment opportunity.

User Image ForcedToRetire Posted - 2 hours ago

$AVXL @georgejjl Below $4 tomorrow 192 week low. Where's the weekly GREAT NEWS you've said was coming?

User Image Labrador47 Posted - 2 hours ago

$AVXL All growth stocks are down. Let's see what AVXL presents tomorrow.

User Image redbugs Posted - 3 hours ago

$AVXL IT IS SO DIFFICULT TO ADMIT THAT AF WAS CORRECT. HE SAW CLEARLY WHAT WE COULD NOT, OR REFUSED, TO SEE.........THAT THE COMPANY IS A FRAUD AND NEVER HAD FAVORABLE DATA.

User Image McNibbler Posted - 3 hours ago

$AVXL bears can go step on a Lego.

User Image robseip Posted - 3 hours ago

$AVXL

User Image papatrick Posted - 5 hours ago

$AVXL it came close...4.03..lets retry tomorrow with Missling lies, it should go easy Eventually..heu...soon

User Image sacs Posted - 5 hours ago

$AVXL Everyone who sues will win. As a CEO, you can't say "surprise" and then sell shares. It's insider trading with background knowledge.Missling screwed up

User Image iknowurmom Posted - 5 hours ago

$AVXL I dont believe this has hit bottom yet... will look to accumulate some additional shares at 3.79

User Image stocksNstuff Posted - 5 hours ago

$AVXL 🍿

User Image Blarcamesine Posted - 5 hours ago

$AVXL so close .

User Image rrogozin Posted - 5 hours ago

$AVXL I guess 3's next, damn.

User Image JV716 Posted - 5 hours ago

$AVXL 192 WEEK LOW AS MISSLING SPEAKS TOMORROW AND TRADE UNDER $4 AS HE BEGS FOR MONEY

User Image imatrader65 Posted - 5 hours ago

$AVXL come on fill my 2k order before she go green!

User Image hichemben Posted - 6 hours ago

$AVXL Double my position today - I’m very surprised we are hitting new 52wk lows! We need a news asap to get back on track! 🚀

User Image sacs Posted - 6 hours ago

$AVXL

User Image DNDN Posted - 6 hours ago

$AVXL $AVXL will triple/quadruple if they announce EMA filing!!

User Image greedo Posted - 6 hours ago

$AVXL Countdown to the 3's boys and girls..

User Image SuavePete412 Posted - 6 hours ago

$AVXL Yup the normal end of day slide is here. How many consecutive days have we hit new lows?

User Image Blarcamesine Posted - 7 hours ago

$AVXL you know what they say .. you can take the company out of the pink sheets, but you can't take the pink sheets out of the company!!

User Image Burg2532 Posted - 7 hours ago

$AVXL you might need to get on some meds.

User Image Blarcamesine Posted - 7 hours ago

$AVXL on another separate note. . It's time to say goodbye by ANVS . Alzheimers and parkinson's are hard!

User Image Blarcamesine Posted - 7 hours ago

$AVXL yes . Investors are green with anger! Where is FDA or EMA news! It's past time . .for that.

User Image Lilac Posted - 7 hours ago

$AVXL Ok time for Green!

User Image papatrick Posted - 8 hours ago

$AVXL missed it by 5 cents...launch the line again....give me 4 and i ll take the risk to trust Messthings again

User Image Blarcamesine Posted - 8 hours ago

$AVXL he sold at a great price! Like he got away with something

User Image Druids Posted - 8 hours ago

$AVXL how's Missling doing?

User Image JV716 Posted - 8 hours ago

$AVXL

Analyst Ratings
HC Wainwright & Co. Buy Jan 3, 24
HC Wainwright & Co. Buy Nov 28, 23
HC Wainwright & Co. Buy Aug 8, 23
HC Wainwright & Co. Buy Jul 20, 23
HC Wainwright & Co. Buy Jun 29, 23
HC Wainwright & Co. Buy May 2, 23
HC Wainwright & Co. Buy Mar 31, 23
BTIG Buy Feb 9, 23
HC Wainwright & Co. Buy Feb 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MISSLING CHRISTOPHER U President and CEO President and CEO Jun 28 Sell 7.98 268,000 2,138,640 1,018,210 06/30/23
MISSLING CHRISTOPHER U President and CEO President and CEO Jun 28 Option 1.6 500,000 800,000 1,250,210 06/30/23
Skarpelos Athanasios Director Director May 25 Option 0.92 50,000 46,000 1,356,458 05/27/22
Skarpelos Athanasios Director Director May 25 Sell 9.06 50,000 453,000 1,306,458 05/27/22
MISSLING CHRISTOPHER U President and CEO President and CEO Jul 01 Option 1.32 51,620 68,138 1,069,830 07/01/21
MISSLING CHRISTOPHER U President and CEO President and CEO Jul 01 Sell 26 51,620 1,342,120 1,018,210 07/01/21
Boenisch Sandra PFO and Treasurer PFO and Treasurer Jul 01 Option 4.96 166,696 826,812 189,659 07/01/21
Boenisch Sandra PFO and Treasurer PFO and Treasurer Jul 01 Sell 26.53 166,696 4,422,445 22,963 07/01/21
FAVUS ELLIOT Director Director May 25 Option 4.12 145,000 597,400 145,000 05/25/21
FAVUS ELLIOT Director Director May 25 Sell 11.7 145,000 1,696,500 05/25/21
FAVUS ELLIOT Director Director Feb 26 Option 2.93 145,500 426,315 145,000 02/26/21
FAVUS ELLIOT Director Director Feb 26 Sell 12.66 145,500 1,842,030 02/26/21
Donhauser Peter D.O. Director Director Feb 23 Buy 12.8 1,165 14,912 1,165 02/23/21